Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 4 Grant or award Director acquired 2,129 shares (grant or award)
  2. 4 Grant or award Director acquired 1,380 shares (grant or award)
  3. 4 Grant or award Director acquired 2,616 shares (grant or award)
  4. 4 Grant or award Director acquired 5,014 shares (grant or award)
  5. 4 Grant or award Director acquired 2,761 shares (grant or award)
  6. 4 Grant or award Director acquired 3,125 shares (grant or award)
  7. 4 Open-market buy President & CEO bought 582 shares at $4.81 ($2,799)
  8. 4 Open-market buy Chief Medical Officer bought 1,768 shares at $4.81 ($8,504)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Director acquired 1,011 shares (grant or award)
  12. 4 Grant or award Director acquired 1,703 shares (grant or award)
  13. 4 Grant or award Director acquired 1,703 shares (grant or award)
  14. 4 Grant or award Director acquired 3,673 shares (grant or award)
  15. 4 Grant or award Director acquired 2,076 shares (grant or award)
  16. 4 Grant or award Director acquired 2,129 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 37 · 739 filings